Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma
NCT06278948
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
140
Enrollment
INDUSTRY
Sponsor class
Conditions
Melasma
Interventions
OTHER:
Group TP
DRUG:
Group CYS
Sponsor
Cosmetique Active International